Theophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial.

Autor: Wheeler DS, Jacobs BR, Kenreigh CA, Bean JA, Hutson TK, Brilli RJ

Publikováno v: Pediatric Critical Care Medicine; 2005 Mar, Vol. 6 Issue 2, p142-149, 8p

High nonpublication rate from publication professionals hinders evidence-based publication practices.

Autor: Carey LC; ProScribe-Envision Pharma Group , Sydney, New South Wales , Australia., Stretton S; ProScribe-Envision Pharma Group , Sydney, New South Wales , Australia., Kenreigh CA; Excel-Envision Pharma Group , Southport, CT , United States., Wagner LT; Excel-Envision Pharma Group , Southport, CT , United States., Woolley KL; ProScribe-Envision Pharma Group, Sydney, New South Wales, Australia; University of Queensland, Brisbane, Queensland, Australia; University of the Sunshine Coast, Maroochydore DC, Queensland, Australia.

Publikováno v: PeerJ [PeerJ] 2016 May 10; Vol. 4, pp. e2011. Date of Electronic Publication: 2016 May 10 (Print Publication: 2016).

Roflumilast: the evidence for its clinical potential in the treatment of chronic obstructive pulmonary disease.

Autor: Wagner LT; MLC Solutions Ltd, Galena, Ohio, USA., Kenreigh CA

Publikováno v: Core evidence [Core Evid] 2005; Vol. 1 (1), pp. 23-33. Date of Electronic Publication: 2005 Mar 31.